Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Stock Option Activity (Details)

v3.22.4
Stockholders' Equity - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Shares    
Outstanding (in shares) 24,597,000  
Granted (in shares) 989,000 3,800,000
Exercised (in shares) (363,000)  
Forfeited or cancelled (in shares) (297,000)  
Outstanding (in shares) 24,926,000 24,597,000
Exercisable (in shares) 21,745,000  
Weighted Average Exercise Price    
Outstanding (in usd per share) $ 12.16  
Granted (in usd per share) 13.55  
Exercised (in usd per share) 10.33  
Forfeited or cancelled (in usd per share) 18.40  
Outstanding (in usd per share) 12.17 $ 12.16
Exercisable (in usd per share) $ 11.41  
Weighted Average Remaining Contractual Life (in years)    
Outstanding 4 years 4 months 24 days  
Exercisable 3 years 8 months 12 days  
Aggregate Intrinsic Value    
Outstanding $ 33,481  
Exercisable $ 33,470